Concepedia

Author

Guiling Li

Huazhong University of Science and TechnologyORCID

Also Known As

GUILING LI, Gui-Ling Li, Gui-ling Li, GuiLing Li, Guiling Li, L. Guiling, L.I. Guiling, Li Guiling, Li guiling, Yin Gao

120

Publications

3.2K

Citations

20

H-Index

67

Concepts

All Affiliations

Huazhong University of Science and TechnologyUnion HospitalFudan University Shanghai Cancer CenterHubei Cancer HospitalHunan Cancer Hospital
GL

About

Guiling Li is an author at Huazhong University of Science and Technology specializing in medicine, cell biology, and tumor biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

11

11

877

2

Public Health

3

3

672

3

Engineering

2

2

39

4

Health Sciences

2

2

38

5

Management

1

1

19

Guiling Li

×

29

Publications

3.1K

Citations

20

H-Index

YearCitations

Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak

Mengyuan Dai, Dianbo Liu, Miao Liu,

Cancer Discovery

2020

1.6K

Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study

Kunyu Yang, Yuhan Sheng, Chaolin Huang,

The Lancet Oncology

2020

592

Treatment With Niraparib Maintenance Therapy in Patients With Newly Diagnosed Advanced Ovarian Cancer

Ning Li, Jianqing Zhu, Rutie Yin,

JAMA Oncology

2023

143

Targeting NEK2 impairs oncogenesis and radioresistance via inhibiting the Wnt1/β-catenin signaling pathway in cervical cancer

Tie Xu, Yulan Zeng, Linli Shi,

Journal of Experimental & Clinical Cancer Research

2020

80

Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multi-Center Study During the COVID-19 Outbreak

Mengyuan Dai, Dianbo Liu, Miao Liu,

SSRN Electronic Journal

2020

58

Cadonilimab Combined with Chemotherapy with or without Bevacizumab as First-Line Treatment in Recurrent or Metastatic Cervical Cancer (COMPASSION-13): A Phase 2 Study

Hanmei Lou, Hongbing Cai, Xin Huang,

Clinical Cancer Research

2024

46

Development and Validation of a Prognostic Nomogram to Guide Decision-Making for High-Grade Digestive Neuroendocrine Neoplasms

Zhenyu Lin, Haihong Wang, Yixuan Zhang,

The Oncologist

2019

43

Efficacy and safety of niraparib as maintenance treatment in patients with newly diagnosed advanced ovarian cancer using an individualized starting dose (PRIME Study): A randomized, double-blind, placebo-controlled, phase 3 trial (LBA 5)

Ning Li, Jianqing Zhu, Rutie Yin,

Gynecologic Oncology

2022

42

Follow-up study on serum cholesterol profiles and potential sequelae in recovered COVID-19 patients

Guiling Li, Li Du, Xiaoling Cao,

BMC Infectious Diseases

2021

40

Pamiparib Monotherapy for Patients with Germline <i>BRCA1/2</i> -Mutated Ovarian Cancer Previously Treated with at Least Two Lines of Chemotherapy: A Multicenter, Open-Label, Phase II Study

Xiaohua Wu, Jianqing Zhu, Jing Wang,

Clinical Cancer Research

2021

34

Page 1